<DOC>
	<DOC>NCT02674386</DOC>
	<brief_summary>A4091064 is a multicenter, long-term observational study of subjects from tanezumab interventional studies (regardless of treatment group) who undergo a total knee, hip or shoulder replacement during participation in the study. The study is designed with a total duration of subject follow-up of 24 weeks after the total joint replacement surgery. There will be two methods of data collection utilized in this study: interview by site staff via the telephone and interactive web-response system (or paper if the subject has no access to the internet).</brief_summary>
	<brief_title>Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement</brief_title>
	<detailed_description>A4091064 is a long-term observational follow up study of subjects from tanezumab interventional studies A4091056, A4091057 or A4091058.</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Personally signed and dated informed consent document. Randomized and treated with subcutaneous investigational product in a tanezumab study and has completed the study or been withdrawn from the study. Actual or planned total knee, hip or shoulder replacement surgery during the tanezumab study. Willing and able to comply with scheduled visits and other study procedures. None.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>